Results 11 to 20 of about 3,390 (191)
Vasoplegia is a condition characterized by persistent low systemic vascular resistance despite a normal or high cardiac index, resulting in profound and uncontrolled vasodilation. Vasoplegia may occur due to various conditions, including cardiac failure,
Iqbal Ratnani +3 more
doaj +4 more sources
Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass
Vasoplegia is defined by hypotension and low systemic vascular resistance despite the normal or elevated cardiac index, a complication frequently following cardiac surgery, carrying high morbidity and mortality rate. Vasoplegia is related with a profound systemic inflammatory response and is mainly mediated by cellular hyperpolarization, a relative ...
Rizal Muhammad +3 more
openaire +4 more sources
Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass [PDF]
Abstract Purpose Vasoplegia often complicates on-pump cardiac surgery. Systemic inflammatory response induced by extracorporeal circulation represents the major determinant, but adrenal insufficiency and postoperative vasopressin deficiency may have a role.
Pasero, D +14 more
openaire +4 more sources
Angiotensin II: A Multimodal Approach to Vasoplegia in a Cardiac Setting
Patients experiencing vasoplegia, a type of distributive shock, have limited options when conventional vasopressors are not appropriate or sufficient.
William Sovic +10 more
doaj +2 more sources
Background Vasoplegia after routine cardiac surgery is associated with severe postoperative complications and increased mortality. It is also prevalent in patients undergoing implantation of pulsatile flow left ventricular assist devices (LVAD). However,
Eric E. C. de Waal +6 more
doaj +2 more sources
Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment [PDF]
Prolonged postoperative vasoplegia is known to occur following cardiac surgery in patients on chronic angiotensin II receptor blocker (ARB) treatment in adults. The perioperative management of these drugs in the pediatric population is not well described
Nischal R. Pandya +10 more
doaj +3 more sources
Methylene Blue and Vasoplegia: Who, When, and How?
Systemic inflammatory response can be associated with clinically significant and, at times, refractory hypotension. Despite the lack of uniform definitions, this condition is frequently called vasoplegia or vasoplegic syndrome (VS), and is thought to be due to dysregulation of endothelial homeostasis and subsequent endothelial dysfunction secondary to ...
S Peter, Stawicki +4 more
openaire +3 more sources
Vasoplegia treatments: the past, the present, and the future [PDF]
Vasoplegia is a ubiquitous phenomenon in all advanced shock states, including septic, cardiogenic, hemorrhagic, and anaphylactic shock. Its pathophysiology is complex, involving various mechanisms in vascular smooth muscle cells such as G protein-coupled
Bruno Levy +5 more
doaj +3 more sources
Octreotide is a somatostatin analog known for its role in the treatment of acute variceal bleeding, enterocutaneous fistula and carcinoid syndrome. The reduction of portal pressure from splanchnic vasoconstriction has been attributed to the inhibition of
Wendell H Williams +4 more
doaj +2 more sources
The Use of Methylene Blue during Liver Transplantation for Vasoplegia [PDF]
The use of methylene blue for vasoplegia in cardiac cases with cardiopulmonary bypass, septic shock, and acute liver failure is well documented. Use of MB for liver transplantation has been largely limited to case reports. We describe three separate liver transplantation patients with significant hypotension following reperfusion.
Paul Harding +2 more
openaire +4 more sources

